House AA, Wanner C, Sarnak MJ, et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019; 95:1304-1317.
McCullough PA. Cardiorenal syndromes: Pathophysiology to prevention. Int J Nephrol 2010; 2010:762590.
McCullough PA, Ahmad A. Cardiorenal syndromes. World J Cardiol 2011; 3:1–9.
Rangaswami J, et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis and treatment strategies: A scientific statement for healthcare professionals from the American Heart Association. Circulation 2019; 139:e840–e878.
Haase M, et al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182:99–116.
McCullough PA, Verrill TA. Cardiorenal interaction: Appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease. Postgrad Med 2010; 122:25–34.
Cruz DN, et al. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182:117–136.
Bagshaw SM, et al. Cardiorenal syndrome type 3: Pathophysiologic and epidemiologic considerations. Contrib Nephrol 2013; 182:137–157.
Larsen T, et al. Type 4 cardiorenal syndrome: Myocardial dysfunction, fibrosis, and heart failure in patients with chronic kidney disease. J Clin Exp Cardiol 2012; 3:4. DOI: 10.4172/2155-9880.1000186
Tumlin JA, et al. Cardiorenal syndrome type 4: Insights on clinical presentation and pathophysiology from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182:158–173.
McCullough PA. Future therapeutic prospects for treatment of cardiorenal syndromes. In: Cardio-Renal Clinical Challenges, edited by Goldsmith DA, Covic A, Spaak J.,Springer International Publishing AG, 2015, pp. 189–195.
McCullough PA, et al. Nutritional deficiencies and sarcopenia in heart failure: A therapeutic opportunity to reduce hospitalization and death. Rev Cardiovasc Med 2016; 17:S30–S39.
Rangaswami J, McCullough PA. Heart failure in end-stage kidney disease: Pathophysiology, diagnosis, and therapeutic strategies. Semin Nephrol 2018; 38:600–617.
Larsen T, et al. A lethal case of influenza and type 5 cardiorenal syndrome. Crit Care Med 2013; 41:1296.
Mehta RL, et al. Cardiorenal syndrome type 5: Clinical presentation, pathophysiology and management strategies from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182:174–194.
Ostermann M, et al. Kinetics of urinary cell cycle arrest markers for acute kidney injury following exposure to potential renal insults. Crit Care Med 2017; 46:375–383.
Tecson KM, et al. Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study. BMJ Open 2017; 7:e016028.